Abbott Laboratories (ABT)

Short-Term Debt

$3.01B

Quarterly · Period ending: · USD

ABT logo

ABT Short-Term Debt

Latest reported$3.01B
ABT Quarterly Short-Term Debt ($122.90M → $3.01B)
High-resolution chart · PNG

ABT short-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories Short-Term Debt — Quarterly (USD)
Period endingShort-Term Debt (USD)
3,005,000,000
4,409,000,000
3,309,000,000
1,345,000,000
507,000,000
506,000,000
1,754,000,000
2,154,000,000
1,615,000,000
2,010,000,000
1,325,000,000
1,051,000,000
2,284,000,000
2,285,000,000
2,481,000,000
1,117,000,000
5,000,000
4,000,000
999,000,000
951,000,000
954,000,000
955,000,000
461,000,000
214,000,000
1,495,000,000
1,468,000,000
1,683,000,000
1,660,000,000
415,000,000
405,000,000
207,000,000
4,274,000,000
847,000,000
737,000,000
714,000,000
715,000,000
221,000,000
210,000,000
1,325,000,000
2,535,000,000
2,896,000,000
2,613,000,000
3,130,000,000
2,402,000,000
2,899,000,000
2,972,000,000
4,437,000,000
4,582,000,000
3,962,000,000
4,378,000,000
3,173,000,000
4,859,876,000
4,523,778,000
3,635,850,000
2,391,000,000
4,224,991,000
6,082,923,000
4,785,435,000
3,374,755,000
3,624,561,000
5,591,350,000
6,251,963,000
6,394,766,000
5,806,372,000
5,868,394,000
6,448,520,000
5,189,620,000
4,077,730,000
4,331,830,000
4,038,282,000
2,731,975,000
2,096,462,000
5,427,123,000
4,179,156,000
2,725,915,000
5,764,391,000
5,720,842,000
5,935,472,000
5,401,261,000
1,937,133,000
2,251,778,000
2,140,839,000
2,062,010,000
3,533,230,000
1,016,946,000
2,478,208,000
1,992,683,000
1,853,199,000
2,280,123,000
1,727,595,000
2,537,357,000
2,719,143,000
1,828,120,000
2,199,789,000
2,148,654,000
2,480,947,000
2,390,909,000
2,576,102,000
2,953,335,000
2,920,266,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.